Sulprim

Quick links to important sections

Sulprim

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Sulprim

What is Sulprim?

Sulprim is a combination antibacterial medication composed of two active ingredients: sulfamethoxazole and trimethoprim. These two components work together to inhibit the growth and spread of certain types of bacteria. By interfering with the metabolic processes of the microorganisms, the medication helps the body's immune system manage and resolve various bacterial infections.

Composition and Mechanism

Sulprim belongs to a class of medications known as sulfonamides (for the sulfamethoxazole component) and folic acid antagonists (for the trimethoprim component). The combination is often referred to as co-trimoxazole.

  • Sulfamethoxazole works by preventing bacteria from producing dihydrofolic acid.
  • Trimethoprim blocks the subsequent step in the same metabolic pathway, preventing the production of tetrahydrofolic acid.

Because bacteria require these folate derivatives to synthesize nucleic acids and proteins, this dual action effectively disrupts their ability to reproduce.

Common Uses

Sulprim is utilized in clinical settings to treat a variety of systemic and localized bacterial infections. Its broad-spectrum nature makes it effective against various gram-positive and gram-negative organisms. It is frequently used for conditions affecting different systems in the body, including:

  • Urinary Tract: Management of infections involving the bladder or kidneys.
  • Respiratory System: Treatment of certain types of pneumonia, bronchitis, and middle ear infections (otitis media).
  • Gastrointestinal Tract: Management of specific bacterial infections of the intestines.

This medication is specifically designed for bacterial issues and is not effective against viral infections, such as the common cold or the flu.

What side effects are possible with Sulprim?

Possible Side Effects and Safety Information

The safety profile for Sulprim (Sulfadimidine/Trimethoprim) is structured according to official regulatory classifications that detail potential adverse reactions by frequency and affected body system. These categories help define the scope of expected and rare safety characteristics based on governmental prescribing information.


Adverse Reaction Scope

Category Summary of Regulatory Findings
Frequency Classification Very Common (ge 1/10) includes hyperkalemia (elevated potassium levels). Common (ge 1/100 to <1/10) reactions documented include rash, headache, and gastrointestinal disturbances such as nausea and diarrhea.
System-Organ Classes Officially affected systems include Blood and Lymphatic System, Skin and Subcutaneous Tissue, Gastrointestinal disorders, and Renal and Urinary disorders.
Serious Adverse Reactions Regulatory documents highlight Serious Adverse Reactions that are very rare (<1/10,000), such as Severe Cutaneous Adverse Reactions (SCARs) like Stevens-Johnson Syndrome (SJS), severe hematological toxicities (e.g., agranulocytosis, aplastic anemia), and fulminant hepatic necrosis.

Population-Specific Safety Statements

Official labels include specific safety considerations and restrictions for defined patient populations. Older adults are noted to have a greater susceptibility to severe adverse reactions, including increased risks of bone marrow suppression. The medicine is generally contraindicated in infants under a specified age (e.g., 2 months) and in individuals with existing severe renal or hepatic impairment. Furthermore, the risk for severe skin reactions is generally highest during the initial weeks of treatment, and prolonged use is associated with a need for monitoring related to folate depletion.

Overdose and Emergency Response

Overdose and When to Seek Help

An overdose of Sulprim (Sulfadimidine and Trimethoprim) is officially documented to present with acute systemic and gastrointestinal manifestations. These initial signs may include nausea, vomiting, dizziness, headache, and confusion. Overexposure, particularly chronic overdosage, is associated with the potential for severe, life-threatening outcomes affecting major organ systems. Regulatory labeling highlights the risk of acute renal failure due to crystalluria, severe hepatic necrosis, and critical hematological disorders, such as megaloblastic anemia, leukopenia, and thrombocytopenia.

Due to the seriousness of these documented complications, regulatory authorities mandate that patients seek immediate medical attention or contact emergency services immediately upon any suspicion of overdose. Immediate evaluation is also required at the first appearance of serious signs like a rash, sore throat, fever, or jaundice. The risk of severe toxicity is officially noted to be increased in patients with pre-existing renal impairment or folate deficiency.

Management of overdose is officially described as symptomatic and supportive treatment. While no specific antidote is known for the sulfonamide component, Leucovorin (folinic acid) may be administered to counteract the anti-folate effects of trimethoprim. Documented supportive procedures may involve gastric lavage, forced diuresis, and alkalinization of the urine. Continuous monitoring of blood counts and renal and hepatic function is required.

Therapeutic Uses of Sulprim

Sulprim (Sulfadimidine/Trimethoprim) is used in areas where short-term symptom management is appropriate for conditions involving bacterial infections. It plays a role in managing the symptoms associated with acute or episodic changes. This class of medicine is commonly used across major therapeutic domains.


Therapeutic Support and Symptom Management

This medication is relevant in clinical settings that involve acute or unstable symptom patterns, being commonly used for conditions such as Urinary Tract Infections (UTIs), acute otitis media, and certain gastrointestinal conditions like Traveler's Diarrhea and Shigellosis. It helps address symptom clusters that may become intense or disruptive, such as the pain and urgency associated with UTIs or the acute diarrhea and chest congestion linked to bacterial disease. This provides supportive relief when symptoms interfere with routine activities, contributing to improved comfort during periods of heightened symptoms.


The medicine is also applied in addressing conditions involving recurrent or episodic manifestations where reducing the risk of symptomatic episodes is desired. This preventive use is relevant when supportive symptom management is appropriate, as it may assist with maintaining functional stability.

Quick Fact: Relief for Acute Distress
Sulprim is commonly used to help manage symptoms related to physical discomfort and systemic imbalance, assisting with symptoms related to pain, inflammation, and functional strain associated with acute bacterial episodes in the respiratory and urinary tracts.

Eligibility and Restrictions for Use

Who Can and Cannot Use Sulprim?

Eligibility for Sulprim (Sulfadimidine/Trimethoprim), a Potentiated Sulfonamide, is strictly governed by regulatory labeling and is determined by patient age, pre-existing conditions, and physiological status.

Contraindications and Restrictions

Eligibility Status Specific Population or Condition
Absolutely Contraindicated Infants less than two months of age.
Absolutely Contraindicated Patients with known hypersensitivity to trimethoprim or any sulfonamide (sulfa drug).
Absolutely Contraindicated Patients with marked hepatic parenchymal damage or severe renal insufficiency where monitoring is unavailable.
Absolutely Contraindicated Documented megaloblastic anemia due to folate deficiency, or a history of Acute Porphyria.
Contraindicated Use during the first trimester of pregnancy and near term delivery.
Restricted Use Patients with G6PD deficiency or a history of severe atopy or bronchial asthma.
Restricted Use Older adults and patients with moderate renal impairment (CrCl 15–30 mL/min) require caution and potential dose reduction.

Adults and children two months of age and older are the populations for whom use is officially allowed. Nursing mothers are generally advised against use, especially if the infant is premature or jaundiced, due to potential risk of kernicterus.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Sulprim (a fixed combination of sulfamethoxazole and trimethoprim) interacts with several medicinal products and product classes through various mechanisms, as documented in official regulatory labeling.

Contraindicated Combinations

Co-administration with Dofetilide is strictly contraindicated. This interaction increases the plasma concentration of dofetilide, which poses a serious risk of ventricular arrhythmias, including QTc prolongation and Torsades de Pointes.

Clinically Significant Interactions

Interactions often require dose adjustment and close patient monitoring, particularly of laboratory parameters:

  • Oral Anticoagulants (e.g., Warfarin): The drug may potentiate the effect of warfarin by inhibiting its metabolism, necessitating frequent monitoring of the International Normalized Ratio (INR) and anticoagulant dose adjustment.
  • Potassium-Increasing Agents: Co-administration with ACE Inhibitors, ARBs, or Potassium-Sparing Diuretics increases the risk of severe hyperkalemia, especially in elderly patients, requiring close monitoring of serum potassium.
  • Phenytoin and Digoxin: The drug may increase the plasma concentrations of Phenytoin (via metabolic inhibition) and Digoxin (via inhibition of renal tubular secretion), requiring monitoring of drug levels.
  • Methotrexate: The combination is associated with increased Methotrexate toxicity due to possible interference with folate metabolism and competitive inhibition of renal tubular secretion, requiring close monitoring of hematologic parameters.
  • Laboratory Test Interference: The trimethoprim component can interfere with the determination of serum creatinine using the Jaffe reaction, resulting in falsely elevated values.
  • Other Agents: Increased risks have also been documented with Cyclosporine (nephrotoxicity), Pyrimethamine, and certain Oral Hypoglycemics (e.g., Sulfonylureas).

Mechanism of Action

Dual-Point Inhibition of Folate Synthesis Pathway

Sulprim's mechanism of action involves the simultaneous, sequential shutdown of the bacterial processes required for de novo folic acid synthesis. The combination targets two distinct enzymes within this essential metabolic pathway. Sulfadimidine acts as a competitive inhibitor of Dihydropteroate Synthase (DHPS), arresting the initial step where the precursor para-aminobenzoic acid (PABA) is incorporated. Subsequently, Trimethoprim reversibly inhibits Dihydrofolate Reductase (DHFR), stopping the final conversion to tetrahydrofolic acid (THF), an essential co-factor.

Sequential Blockade and Bactericidal Synergy

This simultaneous disruption of two consecutive steps creates a synergistic effect. The exhaustion of essential purines and thymidine precursors results in the halt of DNA and protein synthesis and the death of the bacterial cell. The mechanism converts the individual agents' growth-slowing effect into a combined bactericidal (bacteria-killing) consequence. The mechanism exhibits selectivity, as bacterial DHFR has a significantly greater affinity for Trimethoprim compared to its human counterpart.

Dosage and Administration Information

Administration and Dosing Instructions

Sulprim (sulfamethoxazole and trimethoprim) is available for administration by the oral route (tablet or suspension) or by intravenous (IV) infusion. Correct use is structured by patient-specific criteria and precise procedural steps.


Official Dosing Rules

Patient Group Standard Dosing Frequency Special Condition/Adjustment Rule
Adults and Children ge 40 kg (Oral) Every 12 hours Dose is based on one double-strength tablet (160 mg Trimethoprim/800 mg Sulfamethoxazole).
Children ge 2 Months Every 6, 8, or 12 hours Dose is weight-adjusted and divided across the day; use is not recommended for children under two months.
Impaired Kidney Function Adjusted based on CrCl Dose must be reduced by 50% if creatinine clearance (CrCl) is 15 –30 mL/min. Use is not recommended if CrCl is <15 mL/min.

Administration Procedures

Oral Administration: Tablets and oral suspension may be taken without regard to meals. Each oral dose must be taken with a full glass of water (8 ounces/240 milliliters). The liquid suspension must be measured using a specially marked measuring device for accuracy, not a household spoon.

IV Infusion: The IV formulation must be diluted in 5% Dextrose in Water (D5W) and administered by slow infusion over a period of 60 to 90 minutes, strictly avoiding rapid infusion or bolus injection.

Missed Dose: If a dose is missed, it should be taken as soon as it is remembered. However, if it is almost time for the next dose, the missed dose should be skipped, and the regular schedule resumed. Do not take two doses at the same time to make up for a missed one.

Recent Clinical Evidence

Research evidence / Overview of Studies for Sulprim


Evidence for Use in Urinary Tract Infections (UTIs)

The research base where this medicine was studied in contexts associated with UTIs primarily consists of Randomized Controlled Trials (RCTs) and numerous Systematic Reviews. Research examined how this medicine was observed in studies that included comparators (other options or placebo) in the context of acute episodes. These studies explored fluctuating or unstable symptoms of the urinary tract and were designed to track the rates of Bacteriological Cure (elimination of the organism) and the measured changes in physical discomfort and urgency (Symptom Resolution).

Studies reported how symptoms evolved in the observed populations, and findings describe patterns observed in the studies related to the resolution of the acute episode. Research also monitored the short-term measurements of relapse or recurrence rates over defined observation intervals following the end of the therapy. The continued applicability of older research findings is challenged by the evolving nature of local antimicrobial resistance patterns.


Evidence for Use in Acute Otitis Media (AOM)

Research examining where this medicine was evaluated for AOM is largely built upon Randomized Controlled Trials (RCTs) and Meta-Analyses. These studies explored short-term symptom changes and examined populations of children between certain age ranges. The primary focus of the research was to monitor the rate of Clinical Failure, which was defined in trials as an outcome event such as requiring a switch to an alternative treatment, and the measured changes in outcomes related to physical discomfort like ear pain and fever.

Clinical trials reported measurements of bacteriological clearance in patients with infections caused by susceptible organisms. Research highlights changes measured during the study period related to symptom patterns and the frequency of treatment modification events recorded during the short-term phase. The existing evidence may be limited in its generalizability, as some studies focus on populations who may have specific clinical considerations, such as a documented allergy to penicillin.


Evidence for Use in Traveler's Diarrhea and Shigellosis

The evidence related to acute bacterial gastrointestinal conditions is derived mainly from Short-term Randomized Controlled Trials (RCTs) that explored short-term symptom changes. Outcomes measured in these studies included the total Duration of Acute Symptoms and the time interval to the last measured unformed stool. The research examined populations consisting of adults, adolescents, and children in contexts associated with acute or disruptive episodes.

Findings describe patterns observed in the studies related to the rate at which certain symptoms evolved in the observed populations. Research reported documented clinical markers of disease progression and the measurement of pathogen elimination at the end of the very short-term follow-up intervals, typically ranging from 1 to 7 days. The evidence base remains susceptible to the challenge of rising antimicrobial resistance.


What is Still Uncertain About the Research

The research provides context about what has been observed so far, but several limitations are acknowledged in the scientific literature. Follow-up durations were limited in most trials, focusing on immediate rather than long-term outcomes. Long-term effects are not fully established or well characterized across the overall evidence landscape. Comparative evidence, particularly against newer antibiotic classes, may be lacking in some areas. Overall, evidence highlights what is known and what is still uncertain, and the findings describe group patterns, not individual predictions for personal outcomes.

Key Studies & References

  1. Management of acute otitis media - Database of Abstracts of Reviews of Effects (DARE) - Systematic Review
  2. About Antimicrobial Resistance - CDC (Used for contextualizing resistance and uncertainty)

Frequently Asked Questions (FAQ)

Common questions about Sulprim (FAQ)


Q: What is Sulprim used for besides its main purpose?

Official labeling for this medicine lists multiple approved uses. These indications include the treatment of urinary tract infections, acute ear infections (otitis media), and specific gastrointestinal conditions like shigellosis and traveler’s diarrhea. It is also approved for the treatment and prevention (prophylaxis) of a serious type of pneumonia called Pneumocystis jirovecii Pneumonia (PJP).


Q: Are there other brand names for the medicine in Sulprim?

Yes, the combination of sulfamethoxazole and trimethoprim (the components in this drug class) is widely available globally under various brand names. Common examples found in regulatory documents include Bactrim, Septra, and Sulfatrim, in addition to generic formulations.


Q: Is Sulprim the same as other sulfa-containing drugs?

No, Sulprim is a distinct fixed-dose combination product containing two active ingredients: a sulfonamide (sulfa drug) and trimethoprim. This combination mechanism distinguishes it from other medications that contain only a single sulfa component. Official documents strictly contraindicate the use of Sulprim in patients with a known hypersensitivity to any sulfonamide.


Q: How quickly does Sulprim start to work after the first dose?

According to regulatory pharmacokinetics data, both active ingredients are well absorbed after oral administration. Peak blood levels for the individual components typically occur between 1 to 4 hours after the dose.


Q: How long does Sulprim stay in your system?

The official product information lists the mean serum half-life for the components as approximately 8 to 10 hours. Based on this data, it can take approximately 40 to 50 hours for the majority of the drug to be cleared from the system.


Q: Can Sulprim be taken if I am allergic to penicillin?

There is no official regulatory statement that contraindicates use based on a penicillin allergy. However, the drug is strictly contraindicated for individuals with a known allergy or hypersensitivity to sulfonamides or trimethoprim, which are its active ingredients.


Q: What kind of food or drinks should be avoided while taking Sulprim?

The oral medicine may be taken without regard to meals. Official administration instructions note that each oral dose should be taken with a full glass of water (8 ounces/240 milliliters). While the label does not restrict specific foods, the IV formulation is noted to potentially interact with propylene glycol.


Q: Is it safe to drink alcohol in moderation while on Sulprim?

Regulatory information indicates that co-administration with alcohol (ethanol) may lead to unpleasant side effects, such as flushing, fast heartbeats, nausea, and vomiting. Official labeling notes that patients are generally advised to avoid or limit alcohol intake.


Q: Is Sulprim safe for older adults (seniors)?

Official safety information notes that older adults may have an increased risk for certain severe adverse reactions, including issues related to blood cell production, severe skin reactions, and high potassium levels. Official labeling describes that dose adjustments are often considered for this population due to the greater susceptibility to certain adverse reactions.


Q: Can Sulprim affect blood sugar levels?

This drug is known to interact with certain diabetes medications. Regulatory documents indicate that it can potentiate the effects of oral hypoglycemic medicines like sulfonylureas, which can result in low blood sugar (hypoglycemia). This interaction has been described in official documents as potentially warranting additional blood glucose monitoring when the drugs are co-administered.


Q: Are there known interactions between Sulprim and birth control pills?

Yes, the sulfonamide component in this medicine may reduce the effectiveness of certain oral contraceptives that contain ethinyl estradiol. This interaction is associated with an increased risk of breakthrough bleeding or unintended pregnancy.


Q: Does Sulprim interfere with vitamins or supplements?

The medicine works by interfering with the synthesis of folic acid (a B vitamin). Use is contraindicated in patients with a known folate deficiency. Official documents note that supplementation may be considered if a folate deficiency is suspected. Regulatory guidance emphasizes the importance of disclosing all vitamins and supplements to the prescribing physician.


Q: Can Sulprim be used long-term for recurring issues?

The drug is approved for long-term use (prophylaxis) for certain conditions, such as PJP. For any prolonged or chronic use, official documents note that close and regular monitoring of blood counts, kidney function, and liver function is necessary to detect potential toxicity.


Q: Is there a maximum amount of time Sulprim should be used?

The duration of use is determined by the infection being addressed. For example, some conditions require a course as short as 5 days, while others require treatment of 14 to 21 days or continuous prophylaxis for months. Regulatory documents do not list a single maximum time limit that applies to all uses.


Q: How long after finishing Sulprim can I take other medications?

The drug’s components have an average half-life of 8 to 10 hours. Due to this clearance rate, it typically takes approximately 40 to 50 hours for the majority of the drug to be eliminated from the system.


Q: Is it required to finish the entire Sulprim prescription even if I feel better?

Regulatory documents contain warnings that failing to complete the prescribed course of treatment may be a contributing factor to the development of drug-resistant bacteria.


Q: Does Sulprim cause problems with sleep?

Official adverse reaction lists include reports of central nervous system effects. These can include feelings of drowsiness as well as difficulties with sleep, such as insomnia.


Q: Is it normal to feel tired or dizzy when taking Sulprim?

Reported adverse reactions include feelings of fatigue and dizziness. Official information notes that reactions such as fatigue and dizziness have been reported, and these effects may impair a person’s ability to perform tasks requiring vigilance, such as driving or operating complex machinery.


Q: Does Sulprim cause anxiety or mood changes?

Adverse effects on the central nervous system have been reported in official documents, including psychiatric issues such as depression and hallucinations.


Q: Can Sulprim cause ringing in the ears (tinnitus)?

Ringing in the ears, known as tinnitus, is listed as a potential adverse reaction to this medication.


Q: Can Sulprim make me more sensitive to the sun?

Official labeling notes that the medicine can cause photosensitivity, meaning an increased sensitivity to sunlight or UV light exposure. Official labeling notes that patients are advised to limit sun exposure while using this drug due to the potential for photosensitivity.


Q: Can Sulprim cause dark urine or other changes in bathroom habits?

The drug is primarily eliminated by the kidneys, and official documents note the potential for disturbances in the renal and urinary system. The label specifically mentions the potential for crystalluria (crystals in the urine) and, rarely, signs of kidney injury.


Q: Does Sulprim interact with common pain relievers like ibuprofen?

While the labeling does not specifically list ibuprofen, it warns of interactions with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and other agents that may increase potassium levels. Using this medicine with NSAIDs can heighten the risk of severe hyperkalemia (high potassium levels).


Q: How common is an allergic reaction to Sulprim?

Official regulatory documents list allergic reactions in both the common category (e.g., rash, hives) and the very rare category, which includes life-threatening reactions like Stevens-Johnson Syndrome (SJS). The risk for the most severe skin reactions is generally highest during the initial weeks of treatment.


Q: Is Sulprim used for preventing infections or just treating them?

The drug is formally approved for both the treatment and prevention (prophylaxis) of certain bacterial infections. Prophylactic uses include prevention of Traveler's Diarrhea and Pneumocystis jirovecii Pneumonia (PJP) in at-risk patient groups.


Q: Is Sulprim safe to take with common cold medicines?

The official label warns that many over-the-counter (OTC) medicines, as well as herbal products, can potentially affect this drug. Official labeling emphasizes the need for patients to check the labels of OTC medicines for alcohol content or ingredients that may interact, as specific interaction advice for all cold medicines is not provided.


Q: Do children usually tolerate Sulprim well?

The drug is indicated for children two months of age and older, with pediatric pharmacokinetic studies suggesting drug levels are comparable to adults. However, the label contains a warning about limited data concerning the safety of repeated use in children under two years of age.


Q: Is Sulprim safe to handle if I am pregnant or breastfeeding?

Official regulatory documents indicate that use is not recommended during the first trimester of pregnancy and near term delivery due to the potential for fetal harm. The drug is excreted in breast milk, and the label recommends caution, particularly if the infant is jaundiced or premature.

How should Sulprim be stored and disposed of?

The official regulatory labeling requires Sulfamethoxazole and Trimethoprim (Sulprim) tablets to be stored at Controlled Room Temperature, defined as 20^circ to 25 C (68^circ to 77 F). The medicine must be protected from light and dispensed in a tight, light-resistant container. Handling instructions strictly prohibit freezing the product. For child safety, the medicine must be kept out of the sight and reach of children.

Disposal should utilize a drug take-back program. If a program is unavailable, unused medicine must be mixed with an undesirable substance (e.g., dirt), sealed in a container, and discarded in the household trash. Personal information must be scratched out from the label before disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Sulprim found in:

A-Z Index: